This excerpt taken from the EDEN 8-K filed Feb 22, 2008.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including the Company's expectation that it can regain compliance with the minimum bid price by effecting a reverse stock split. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms or other terminology. Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The Companys actual results may differ materially from those expressed or implied by these forward-looking statements based on a number of factors, including the Company's inability to regain compliance with Nasdaq's minimum bid price requirement for continued listing, the risk that the Company may not have sufficient funds to operate its remaining business, the potential cost, speculative nature and risks associated with the Companys plan to explore opportunities to realize potential value from its remaining business assets, primarily its tax loss carryforwards, the risks associated with the Companys dependence on Plant Health Care, Inc. as the source of harpin protein-based products for the Companys home and garden business, the competitive nature of the markets in which the Company operates, a change in economic conditions, the Companys ability to retain existing customers and to attract new customers, the Companys ability to retain qualified personnel, the Companys anticipated operating losses, uncertainties regarding the availability of additional capital, and the other risks and uncertainties described in Eden Biosciences annual report on Form 10-K for the year ended December 31, 2006, the Companys Quarterly Reports on Form 10-Q, and the Companys other reports filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance upon these forward-looking statements, which speak only as to the date of this release. Eden Bioscience undertakes no obligation to update any forward-looking statements.